Drawing for INFUZENE

USPTO serial 76585873

INFUZENE

Reviewed by CopyMark Law Group

Reg. 2943514Status 710
Filing date
Status date
Registration date
Apr 26, 2005
Examiner
FROMM, MARTHA L
Law office
TMEG LAW OFFICE 106

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with INFUZENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Laminate adhesives for use in vacuum assisted resin transfer processes; laminate adhesives for use in forming laminate layers for aerospace, automotive, marine and sports equipment manufacturing; and laminate adhesives for general industrial laminate applicationsSECTION 8 - CANCELLEDNov 17, 2003

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 4, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 27, 2015CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Oct 28, 2015ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 17, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 17, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 9, 2010C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 9, 2010APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 22, 2010E815TEAS SECTION 8 & 15 RECEIVED
Aug 5, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 19, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 19, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 16, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 16, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 22, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 22, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 26, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 1, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 12, 2005NPUBNOTICE OF PUBLICATION
Nov 30, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 15, 2004ALIEASSIGNED TO LIE
Nov 9, 2004CNEAEXAMINER'S AMENDMENT MAILED
Nov 9, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2004CNEAEXAMINERS AMENDMENT -WRITTEN
Oct 28, 2004DOCKASSIGNED TO EXAMINER
Apr 27, 2004NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance